+ First and foremost, AB recognizes the need to continually improve reliability. Over AB’s 16-year history, dramatic improvements have been achieved, positioning today’s AB cochlear implant system as number one in “Total System Reliability”—the reliability of both the internal and external components combined. Every single patient’s experience matters, so we will continue to make reliability our first priority, driving industry-leading advancements to ensure that our recipients can always depend on their AB cochlear implant systems.
+ While reliability and performance are the most critical considerations when selecting the right cochlear implant system for you or your child, AB understands that size, appearance, and usability are also practical considerations for recipients. Since 1993, AB has decreased the weight of its sound processors by 94% and will continue to research and develop smaller external components for your comfort when wearing the processor. AB is also committed to improving the appearance of our sound processors and enhancing your hearing experience by ensuring that our cochlear implant system is easy for adults and children alike to use in everyday, real-world conditions.
+ Our recipients hear better in real-world situations than patients with other cochlear implant systems.1,2 AB recognizes that you need to be fully informed in order to choose the best cochlear implant system for you or your child. This initiative stresses our commitment to clearly communicate how AB’s unique technology differs from other manufacturers and why these advances matter to your hearing experience. Clarifying these performance differences and the benefits in hearing they deliver will assist patients in their decision-making process and help clinicians support recipients on their journey to hearing with AB.
+ Patients want easy access to information about how they can hear their best with an AB cochlear implant system. Recipients also want quick and simple ways to order accessories for expanding their wearing options. Likewise, clinicians want to easily access data or order replacement parts for patients if needed. With this in mind, AB is dedicated to improving our tools and services to make it easy for patients and clinicians to get whatever they need, whenever they need it.
+ AB recognizes that patients’ access to cochlear implant technology is significantly dependent upon reimbursement by third parties, both private and governmental. For this reason, we remain focused on obtaining and improving reimbursement for unilateral and bilateral cochlear implants, as well as for the external equipment and reprogramming. As part of this initiative, AB will also work with clinicians to assist with insurance reimbursement for billable activities so that recipients can continue to benefit from affordable patient care. We will expand these efforts, working with governments across the globe to ensure that patients worldwide can hear their best with AB’s cochlear implant system.
+ At AB, we understand that our legacy patients—those with prior-generation systems who’ve been with us the longest—want to be assured that we will support them now and always. This initiative affirms that AB will continually support our legacy patients’ equipment, service, and reimbursement needs over the years. We’re committed to staying by your side every step of the way throughout your journey to hearing.
+ Our patients are implanted, programmed, and serviced in locations worldwide. This initiative stresses our commitment to designing and developing products that meet the unique needs of different regions across the globe. We’re also dedicated to obtaining regulatory approval outside of America, not just within, and developing clinical trials internationally. Our focus will remain global, which means that our products, services, and technology must be readily accessible to patients wherever they may reside. It also means that our materials must be translated into the patient’s native language so that they are fully informed along their journey to hearing with AB. We will continue to make our cochlear implant system available to patients worldwide through government tenders, bids, and procurement opportunities.
+ At AB, we recognize that patients deserve a lifelong partner who will continue to service and upgrade their or their child’s device over a patient’s lifetime. In order to maintain lasting relationships with all of our patients over the years, we must deliver profitability to our shareholders and to our other stakeholders so that we remain a global leader now and in the future. This initiative includes measures to ensure that we will remain your partner for life.

AB is committed to delivering reliable cochlear implant systems
to patients.
AB is committed to making improvements on the ease of use and aesthetics of our cochlear implant systems.
AB is committed to communicating the performance differences between devices.
AB is committed to making it easy for patients and clinicians to get what they need.
AB is committed to helping patients and clinicians access appropriate insurance reimbursement.
AB is committed to supporting legacy patients throughout their journey to hearing.
AB is committed to addressing the needs of our patients across
the world.
AB is committed to remaining reasonably profitable in order to be a lifelong partner to our recipients.

About Advanced Bionics

Advanced Bionics® Corporation is a global leader in developing the most reliable, best performing cochlear implant devices in the world. Founded in 1993, AB is the only American company developing cutting-edge cochlear implant technology that restores hearing to the deaf and allows our recipients to hear their best today, tomorrow, and always. We support patients, clinicians, and physicians through the latest scientific research, technology development, educational resources, attentive customer service, community involvement, and more.

AB evolved from two highly successful companies that developed and marketed innovative medical devices; one created new generation pacemakers, and the other developed microinfusion systems (miniature drug delivery pumps used in the treatment of diabetes). Our talented group of technologists and professionals from all over the world are driven to succeed, work with integrity, and stay firmly committed to quality.

Today, AB remains dedicated to improving lives by developing, manufacturing, and distributing the world’s most reliable, best performing cochlear implant system.

Our Mission

At AB, our mission is to improve lives by developing, manufacturing, marketing, and supporting high-quality, state-of-the-art hearing technology for those with severe to profound hearing loss.

Our commitment to providing the best possible hearing experience for our recipients by putting patients first remains at the forefront of all that we do. The trust our recipients place in us is the highest honor and inspires us to strive for excellence each and every day.

Our Culture

Our culture is best described by our people: highly intelligent, spirited, ambitious, and dedicated. We attract innovative technologists and distinguished professionals from all over the world who are committed to improving the lives of those with severe to profound hearing loss.

The culture of AB is shaped daily by our unique mission, the leaders who successfully drive the business, and the staff members from all across the globe who help our recipients hear their best.

"We are building a company with a culture where reliability matters most, where innovation and time to market are the keys to our financial success, where crazy ideas are encouraged, where discipline and teamwork are part of our fabric, and where our employees understand the privilege of being engaged together in a business whose mission is to improve the lives of others."

—Jeff Greiner, President and Co-Chief Executive Officer

Our Focus

At AB, we focus on putting patients first in everything that we do. As part of our firm commitment to patients, we’ve enacted eight core initiatives, each designed to improve the lives of our recipients on their journey to hearing with AB.

Reliability: Deliver reliable cochlear implant systems.
Improvements: Make improvements on ease of use and aesthetics of our cochlear implant systems.
Communicate Differences: Communicate the performance differences between devices.
Make It Easy: Make it easy for patients and clinicians to get what they need.
Reimbursement: Help patients and clinicians access appropriate insurance reimbursement.
Legacy Patients: Support legacy patients throughout their journey to hearing.
Global Company: Address the needs of our patients across the world.
Lifelong Partner: Remain reasonably profitable in order to be a lifelong partner to our recipients.

Leadership

Jeff Greiner
President and Chief Executive Officer

A lawyer by training and an Air Force Academy graduate, Jeff Greiner has been the operational leader of Advanced Bionics® from its beginning.

He served a commitment to the Air Force as part of the Judge Advocate General’s Department. He left the Air Force in 1986 and became the Associate General Counsel for Siemens-Pacesetter and the Acting General Counsel for MiniMed Technologies, Limited, the predecessor entity which produced both MiniMed, Inc. and Advanced Bionics Corporation.

In 1992, Mr. Greiner left Siemens-Pacesetter to lead and build AB into a leading neurological device company. He has grown the company from seven employees in 1992 to over 600 employees in 2009 with an emphasis on leadership and the creation of an innovative and spirited culture, where creativity and discipline are the keys to producing exceptional technology that improves lives.

He holds a B.S. degree in Economics with highest honors from the United States Air Force Academy (1974), a JD degree from UCLA (1977), and an LLM with highest honors from George Washington University (1985).

Al Mann
Chairman and Founder

Alfred E. Mann serves as Chairman of the Board and CEO of MannKind Corporation, a diversified biopharmaceutical company focused on the development of novel therapeutics and drug-delivery technologies for the treatment of diabetes, cancer, autoimmune, and inflammatory diseases. MannKind’s lead product mimics the insulin kinetics of a normal pancreas, creating a new therapy paradigm for diabetes. In 1993, Mr. Mann also founded and began serving as Chairman and co-CEO of Advanced Bionics Corporation (“"Bionics”).

Additionally, Mr. Mann founded and served as the Chairman of the Board and Chief Executive Officer of MiniMed, Inc. from its founding in 1993 until August 2001 when it was acquired by Medtronic, Inc. MiniMed and its Medical Research Group, Inc. affiliate develop, manufacture, and distribute microinfusion systems and continuous glucose monitoring systems that have revolutionized the treatment of Type 1 diabetes. Mr. Mann also founded and was Chairman of the Board and CEO of Pacesetter Systems, Inc., which developed, manufactured, and distributed cardiac pacemakers from 1972 until 1985 when it was acquired by Siemens, AG. From 1985 to September 1992, Mr. Mann continued to serve as Chairman and CEO of the successor company, Siemens-Pacesetter, Inc.; Pacesetter is now the Cardiac Rhythm Management unit of St. Jude Medical. Prior to 1972, he was President of Spectrolab, an electro-optical and aerospace systems company, and Heliotek, a semiconductor and electro-optical components manufacturer. Mr. Mann founded these companies in 1956 and 1960, respectively, sold them to Textron, Inc. in 1960, and continued to lead them until 1972, when he left for Pacesetter. They are now part of the Boeing Company.

Mr. Mann also founded and is non-executive Chairman of (i) Second Sight, which is developing a visual prosthesis to restore sight to the blind; (ii) Implantable Acoustics, which is developing implantable hearing aids; (iii) NeuroSystec, which is exploring drug therapies to treat tinnitus and other audiologic problems; (iv) Bioness, which is pursuing prosthetics to address functional neural deficits by electrostimulation; (v) Dermaport, which is developing novel percutaneous seals for dialysis and other applications; (vi) Quallion, which develops, manufactures, and markets advanced batteries for medical, aerospace, and military applications; and (vii) Stellar Microelectronics, which produces micro-circuit assemblies.

Mr. Mann is currently Chairman of the Board of Trustees of the Alfred Mann Foundation and of the Alfred Mann Institutes at the University of Southern California, Purdue University, and The Technion Institute (Israel)—medical research foundations founded and endowed principally by Mr. Mann, with others in process. He also serves as a Trustee for the University of Southern California, as a member of the Board of Overseers of the Keck USC School of Medicine, and as the Chairman of the Southern California Biomedical Council, a nonprofit association dedicated to the fostering of the bio-medical industry in the Los Angeles Metropolitan area. Mr. Mann holds B.A. and M.S. degrees in physics from the University of California, Los Angeles and honorary doctorate degrees from the University of Southern California, The Johns Hopkins University, Western University, and the Technion Institute (Israel).

View some of Mr. Mann's accomplishments.

Mr. Mann is a member of the National Academy of Engineering and has received dozens of honors, including the following:

Group Achievement Award (NASA, 1981)
Exceptional Public Service Award (NASA, 1984)
Pioneer in Cardiac Pacing (Cardiostim, 1988)
Master Entrepreneur of the Year (Los Angeles, 1996)
Arthur Anderson Award for Fostering Innovation (Southern California, 1996)
Citation Award; Engineer of the Year (UCLA, 1997)
APEX Award for Outstanding Product Design of the Year (for MiniMed Insulin Pump) (The Management Roundtable, 1997)
Father of the Year (Juvenile Diabetes Foundation, 1998)
Lifetime Achievement Award (Independent Living Center of So. California, 1998)
Eleanor Roosevelt Humanitarian Award (League for the Hard of Hearing, 1998)
Pioneer in Cardiac Pacing (50th Anniversary of Cardiostim, 1998)
Man of the Year (San Fernando Valley Economic Alliance, 1998)
Appreciation Award from The Children of PADRE (PADRE Foundation, 1998)
School of Engineering Award (USC, 1999)
Spirit of Edison Award for Community Service (Thomas Edison State College, 1999)
Man of the Year (WISE Senior Services, 1999)
Vision of the Future Award (RP International, 1999)
Humanitarian of the Year (House Ear Institute, 1999)
Named "One of the 10 Most Influential People on the Tech Coast” (Los Angeles Times, 1999)
Reynolds Society Achievement Award (Harvard University, 1999)
Golden Platter Honoree (American Academy of Achievement, 2000)
Fellow of the American Institute of Medical and Biological Engineering (2000)
Heart of a Child Award (Cardiac Arrhythmia Research and Education Foundation, 2000)
Elie Wiesel Humanism in Healing Award (Western University, 2002)
Business Person of the Year Award (Los Angeles Business Journal, 2003)
Invited Speaker (Western University Graduation, 2003)
Keynote Address to INS Congress (Madrid, 2003)
Spirit of Los Angeles Award (United Way, 2003)
Albert Schweitzer Leadership Award (Hugh O'Brian's Youth Organization, 2003)
Ernest Borgnine Spirit Award (American Veterans Association, 2003)
Business Leader and Humanitarian of the Year Award (Jewish Vocational Service, 2004)
Albert Einstein Award for Outstanding Achievement in the Life Sciences (Life Sciences, 2004)
Keynote Speaker at Medtech Insight Conference (Irvine, 2004)
Keynote Speaker at SRI Conference (San Francisco, 2004)
Case Western Reserve University, Deioma Lecture Series (Engineering for Success, 2004)
Phoenix 2004 Innovator Award (Phoenix Medical Device Conference, 2004)
Diabetes Innovator Award (Diabetes Technology Conference, Philadelphia, 2004)
Honored as "American Friend of Rabin Medical Center" (New York, 2004)
Robert A. Schindler, M.D. Endowed Lecturer (University of California, San Francisco, 2004)
Honoree at Eye Birth Defects Dinner (Los Angeles, 2005)
Invited speaker, Metabolic Drug Discoveries (San Francisco, 2005)
Leader of Today Honoree, UCLA Health Services Alumni Association (UCLA, 2005)
Lifetime Achievement Award in Medical Devices Industry (Frost & Sullivan, 2005)
Von Liebig Lecturer (University of California San Diego, 2005)
Neel Distinguished Research Lecturer (AAO, Los Angeles, 2005))
Speaker, "Artificial Pancreas: Closing the Loop" (NIH, Bethesda, MD, 2005)
Keynote Speaker at Caltech MIT Enterprise Forum (2005)
Keynote Address, Mountain West Biomedical Engineering Conference (University of Utah, 2005)
Keynote Address, CIBC Conference (New York, 2005)
Keynote Address, National Academy of Engineers (October 2005)
Spirit of Life Award, Larry King Cardiac Foundation (November, 2006)
New Freedom Award, 9th Intl. Congress on Community Services (December, 2006)
Invited Speaker, Intl. Conference on Aging (Florida, 2006)
Keynote, American Institute for Medical and Biological Engineering (Washington D.C. 2006)
Keynote, National Institutes of Health (Washington D.C. 2006)
Lifetime Achievement Award (L.A. Venture Association, 2007)
Research Professor (University of Southern California, 2002)
Adjunct Professor, Dept. of Bioengineering (University of California, Los Angeles, 2005)
Honorary Doctor of Humane Letters Degree (University of Southern California, 2001)
Honorary Doctor of Humane Letters Degree (The Johns Hopkins University, 2001)
Honorary Doctor of Humane Letters Degree (Western University, 2002)
Honorary Doctor Degree (Technion Institute, Israel, 2005)
Member, National Academy of Engineering (2000)
Member, Board of Directors of United Cerebral Palsy Research and Educational Foundation (2005)
Member, Board of Directors of Nevada Cancer Institute (2005)
Member, Board of Directors, Eclipse Aviation
Member, Board of Directors, Los Angeles Philharmonic

HISTORY

Intrigued by the notion of "helping deaf people hear," Alfred E. Mann founded Advanced Bionics in 1993 and asked Jeff Greiner to lead the fledgling organization of seven engineers and scientists. Since then, Al Mann and Jeff Greiner have been working together to develop state-of-the-art medical technology that improves lives. The seven-person organization they founded has grown to over 600 employees worldwide.

In March 1996, the company received approval from the FDA to market the Clarion® cochlear implant for use in post-lingually deafened adults, and in 1997, received approval to market its cochlear implants for use in children.

Today, AB continues to make industry-leading technological advances with the Harmony® HiResolution® Bionic Ear System (Harmony®). Introduced in 2006, Harmony is the world’s most sophisticated cochlear implant system, using cutting-edge technology to deliver the best possible hearing experience. The Harmony Advantage, only from AB, lets you hear your best everywhere, every time.

AB remains committed to providing recipients with the most reliable, best performing cochlear implant system in the world.

CAREERS

Join the Advanced Bionics Team

Our employees develop, manufacture, market, and support high-quality, state-of-the-art hearing technology for those with severe to profound hearing loss. We consider it a privilege to provide these individuals with the ability to hear words, music, and all the sounds that enrich life. Our passion drives us to apply the most advanced technology available and ensure the best, most reliable hearing experience possible for our recipients.

Everyone who works at AB is dedicated to improving lives by putting patients first. We hire only the best and brightest people and provide them with a thriving work environment that fosters creativity, teamwork, global competitiveness, and professional growth. Our employees come from more than 50 countries, bringing unique perspectives, talent, and dedication that fuel AB’s ability to succeed.

AB pays a competitive salary commensurate with the level of experience and demands of the position. We offer a comprehensive benefits package to full-time employees, including medical, dental, and vision insurance; disability and life insurance; flexible spending account; and 401(k) savings plans. Contact AB for more detailed information regarding the complete list of benefits and opportunities that is currently available.

AB sponsors an annual family picnic and holiday party.
Employee parties are scheduled throughout the year to celebrate milestones and recognize achievements.
Volleyball, basketball, and other outdoor activities are available at our beautiful 63-acre campus in Valencia, California.

Valencia, California, USA
Sylmar, California, USA
Rixheim, France
Tokyo, Japan

We are an equal opportunity employer. Employment selection and related decisions are made without regard to sex, race, age, disability, religion, national origin, color, or any other protected class.

Current Career Opportunities